MarketBeat provides consensus rating data for GRI Bio, Inc., a company listed on Nasdaq that focuses on modulating NKT cells.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provides consensus rating data for GRI Bio, Inc., a company listed on Nasdaq that focuses on modulating NKT cells.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Nasdaq
American fully electronic stock exchange
Related events
- MarketBeat reported analyst ratings for Sarepta Therapeutics and Emergent BioSolutions, both of which are listed on Nasdaq.
- MarketBeat provided average rating data for 20/20 Biolabs, Inc. on July 18, 2026.
- MarketBeat is reporting on consensus ratings for Aehr Test Systems, a company whose stock trades on the Nasdaq exchange.
- MarketBeat provided consensus rating data for Lianhe Sowell International Group Ltd.
- MarketBeat provided consensus rating data and Benzinga reported analyst price objective changes for Prestige Consumer Healthcare.